The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - On Tuesday morning, NuPathe Inc. (NASDAQ:PATH) announced the receipt of an $8.5M term loan, just a month after the company firmed up the balance sheet … Continue Reading
Read nowLong Ideas - Anthera Pharmaceuticals (NASDAQ:ANTH) is getting another lift Wednesday, as the company announced additional data from the Phase IIb PEARL-SC study for its primary value driver, … Continue Reading
Read nowLong Ideas - Gilead Sciences announced Tuesday morning that its Hepatitis C (HCV) candidate sofosbuvir (formerly GS-7977) in combination with ribavirin attained a 78% Sustained Virologic Response (SVR) … Continue Reading
Read nowLong Ideas - Few diseases have a more pressing need for treatment than obesity. For well over a decade, there have been no new obesity drugs on the … Continue Reading
Read nowLong Ideas - Transcept Pharmaceuticals (NASDAQ:TSPT) has struggled to show compelling demand for its primary value driver, Intermezzo, which is marketed by partner, Purdue Pharmaceuticals in the U.S. … Continue Reading
Read nowLong Ideas - Despite closing a $26.1M private financing last Wednesday, shares of MethylGene (TSE:MYG) have yet to respond, but precedents suggest that MYG may be in for … Continue Reading
Read nowLong Ideas - Investors who choose to invest in speculative stocks often choose the biotechnology sector as their sector of choice. It’s easy to understand why; biotechnology companies … Continue Reading
Read now
